Current status and future perspectives of FGF21 analogues in clinical trials
Author:
Funder
National Natural Science Foundation of China
Research Grants Council, University Grants Committee
Publisher
Elsevier BV
Reference95 articles.
1. Obesity and cardiovascular disease: a scientific statement from the American Heart Association;Powell-Wiley;Circulation,2021
2. Inter-organ cross-talk in metabolic syndrome;Priest;Nat. Metab.,2019
3. The impact of organokines on insulin resistance, inflammation, and atherosclerosis;Choi;Endocrinol. Metab.,2016
4. Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine;Tan;Int. J. Biol. Sci.,2023
5. The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic;Geng;Nat. Rev. Endocrinol.,2020
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Endocrine fibroblast growth factors in domestic animals;Domestic Animal Endocrinology;2024-10
2. Dietary medium-chain fatty acids reduce hepatic fat accumulation via activation of a CREBH-FGF21 axis;Molecular Metabolism;2024-09
3. Aged fragmented-polypropylene microplastics induced ageing statues-dependent bioenergetic imbalance and reductive stress: In vivo and liver organoids-based in vitro study;Environment International;2024-09
4. Fibroblast growth factor 21;Differentiation;2024-09
5. Hormone based therapy and crosstalk beyond hormones;Medical Review;2024-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3